Xianruida Medical-B (06669): The registration application for microcatheter V-otter was approved by the China National Drug Administration

Zhitong Finance App News, Xianruida Medical-B (06669) issued an announcement. On December 1, 2025, the Group received approval from the China National Drug Administration to register the microcatheter V-otter. V-otter is suitable for injecting diagnostic, embolic, or therapeutic materials after reaching the intended vascular site during percutaneous peripheral and coronary vascular interventional procedures. V-otter is a microcatheter used in hepatic artery chemoembolization (TACE). It uses a large lumen design to effectively avoid catheter blockage during surgery; the product provides three head end shaping options: straight, 45° single curved and multi-curved, which can calmly adapt to branching blood vessels at different angles according to actual clinical needs, so as to accurately and stably reach the target blood vessels and prepare for subsequent operations. The company will launch marketing activities in China in due course.